Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,576–3,600 of 7,816 matching trials · page 144 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Amyloidosis Incidence in High-Risk Cardiac Device Patients NCT06186167 Chest Wall Fat Tissue Collection Runs in: United States · 1 site |
NA other |
UNKNOWN | 100 | Midwest Heart & Vascular Specialists OTHER |
2024-02-20 |
|
Stress Reduction Study for Partners of Early Stage Dementia NCT03691428 Wish Outcome Obstacle Plan Runs in: United States · 1 site |
NA other |
COMPLETED | 90 | Yale University OTHER |
2024-02-15 |
|
A Global Approach to Tackle Cognitive Decline NCT05479318 Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 1,502 | Chinese University of Hong Kong OTHER |
2024-02-15 |
|
Exercise Training to Improve Cognitive Function NCT03824639 Structured exercise; Health Education Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | VA Office of Research and Development OTHER_GOV |
2024-02-14 |
|
Vascular Cognitive Decline and Dementia NCT06257823 No intervention Runs in: Denmark · 1 site |
NA other |
UNKNOWN | 140 | Aarhus University Hospital OTHER |
2024-02-14 |
|
Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC) NCT03447860 PAACC; REACH-VA Runs in: United States · 2 sites |
NA other |
COMPLETED | 142 | Salem Veterans Affairs Medical Center OTHER_GOV |
2024-02-13 |
|
Study to Evaluate Amyloid in Blood and Imaging Related to Dementia NCT03899844 Blood collection, PiB PET/MRI, and cognitive testing Runs in: United States · 1 site |
NA other |
COMPLETED | 1,122 | Washington University School of Medicine OTHER |
2024-02-13 |
|
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease NCT03938870 L-Leucine 13C6 Runs in: United States · 1 site |
NA other |
COMPLETED | 96 | Washington University School of Medicine OTHER |
2024-02-13 |
|
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints NCT04368416 Runs in: France · 1 site |
NA other |
UNKNOWN | 3,000 | University Hospital, Caen OTHER |
2024-02-13 |
|
Yoga for Caregivers and Persons With Dementia NCT05103839 Gentle Yoga Runs in: United States · 1 site |
NA other |
COMPLETED | 4 | Wake Forest University Health Sciences OTHER |
2024-02-13 |
|
The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia NCT05172687 Overprescribing letter to attributed physician; Placebo letter to a... Runs in: United States · 3 sites |
NA other |
COMPLETED | 336,460 | Columbia University OTHER |
2024-02-13 |
|
Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease NCT05176704 Eye-Tracking Runs in: Canada · 1 site |
NA other |
UNKNOWN | 250 | Innodem Neurosciences INDUSTRY |
2024-02-13 |
|
GnRH Therapy on Cognition in Down Syndrome NCT04390646 GnRH, gonadorelin acetate; 0.9% NaCl Runs in: Switzerland · 1 site |
PHASE2|PHASE3 other |
RECRUITING | 56 | Nelly Pitteloud OTHER |
2024-02-12 |
|
Caring Relationships Expression Study NCT05627687 Heart Rate Variability Biofeedback; Music Listening Control Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 38 | Arizona State University OTHER |
2024-02-12 |
|
Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study NCT05634161 Cognitive improvement software Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 30 | Seoul National University Hospital OTHER |
2024-02-09 |
|
Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training NCT03503669 Memory Training; Kundalini yoga and meditation Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | University of California, Los Angeles OTHER |
2024-02-08 |
|
Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS NCT05830214 Runs in: Canada · 1 site |
NA other |
WITHDRAWN | 0 | University of Alberta OTHER |
2024-02-08 |
|
INTERCEPTOR Project: From MCI to Dementia NCT03834402 Runs in: Italy · 1 site |
NA other |
COMPLETED | 500 | Catholic University of the Sacred Heart OTHER |
2024-02-07 |
|
Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease NCT04855955 Adipose-Derived Mesenchymal Stem Cells |
NA other |
NO_LONGER_AVAILABLE | — | Celltex Therapeutics Corporation INDUSTRY |
2024-02-07 |
|
the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy NCT06245707 prednisone,methylprednisone and cyclophosphamide; Rituximab Runs in: China · 1 site |
NA other |
UNKNOWN | 2 | Beijing Friendship Hospital OTHER |
2024-02-07 |
|
CAMPUS Expanded "Classification and Assessment of Mental Health Performance Using Semantics Expanded" NCT04493736 MHSAFE app recording Runs in: United States · 1 site |
NA other |
UNKNOWN | 2,000 | Clarigent Health INDUSTRY |
2024-02-06 |
|
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease NCT05349318 Hyperbaric oxygen therapy; Sham Runs in: Israel · 1 site |
NA other |
UNKNOWN | 100 | Assaf-Harofeh Medical Center OTHER_GOV |
2024-02-06 |
|
Enhancing Calm in Arab Elderly With Dementia NCT06216275 Integrated Snoezelen-Aromatherapy-Personal Item Therapy Runs in: Egypt · 1 site |
NA other |
UNKNOWN | 80 | Mostafa Shaban OTHER |
2024-02-06 |
|
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease NCT04057807 LPS Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 18 | Yale University OTHER |
2024-02-05 |
|
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder NCT03817931 Anticholinergic; Beta-3 Agonists, Adrenergic; Functional magnetic r... Runs in: United States · 2 sites |
PHASE4 other |
COMPLETED | 12 | Baylor Research Institute OTHER |
2024-02-02 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial